Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. - Duvic,M.; Martin,A.G.; Kim,Y. (Arch Dermatol, 2001)